Die Ophthalmologie最新文献_第5页

[Evidence-based approach for premium intraocular lenses: management of postoperative dissatisfaction]. [优质人工晶状体的循证方法：术后不满意的处理]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-06-13 DOI: 10.1007/s00347-025-02253-3

Isabella D Baur, Arthur Mueller, Grzegorz Łabuz, Gerd U Auffarth, Ramin Khoramnia

引用次数: 0

[Masked threat: primary vitreoretinal lymphoma (PVRL)]. [隐性威胁：原发性玻璃体视网膜淋巴瘤（PVRL）]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-04-09 DOI: 10.1007/s00347-025-02228-4

Tim Rüterhenke, Lynn Zur Bonsen, Jana Ihlow, Simon Schallenberg, Bert Müller, Uwe Pleyer

引用次数: 0

[Bilateral papilledema and its differential diagnoses: a case report]. [双侧乳头水肿及其鉴别诊断1例]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-04-10 DOI: 10.1007/s00347-025-02230-w

Alena Riesmeier, Ekaterina Sokolenko, Carsten Framme

引用次数: 0

[Photobiomodulation for AMD : Statement of the German Society of Ophthalmology, the German Retina Society and the German Professional Association of Ophthalmologists. Status 4 July 2025]. AMD的光生物调节：德国眼科学会，德国视网膜学会和德国眼科专业协会的声明。[2025年7月4日]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 DOI: 10.1007/s00347-025-02303-w

引用次数: 0

[Choroidal rupture following blunt ocular trauma]. [钝性眼外伤后脉络膜破裂]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-08-04 DOI: 10.1007/s00347-025-02290-y

Emma Sieg, Martin S Spitzer, Johannes Birtel

引用次数: 0

[Penetrating keratoplasty postoperative conversion after deep anterior lamellar keratoplasty (DALK)]. [深度前板层角膜移植术（DALK）后穿透性角膜移植术后转化]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-08-14 DOI: 10.1007/s00347-025-02272-0

Mercedes Molero-Senosiaín, Isabeau Houben, Mayte Ariño-Gutierrez, Alexander Stubbing-Moore, Shalom Savant, Vijay Savant

引用次数: 0

[Smoking and eye diseases]. [吸烟与眼疾]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-07-31 DOI: 10.1007/s00347-025-02299-3

Teresa Barth, Johannes Arnds, Sebastian Mohr, Lisa Schreiner, Horst Helbig

引用次数: 0

[Reversible nyctalopia following bariatric surgery in a young woman in Germany]. [一名德国年轻女性减肥手术后的可逆性夜盲症]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-04-11 DOI: 10.1007/s00347-025-02231-9

Mustafa K Hallak, Hermann Krastel, Mirko Otto, Robert P Finger

引用次数: 0

[From indications to outcome-A concise overview of supplementary intraocular lenses]. 【从适应症到结果——辅助人工晶体的简明概述】。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-07-21 DOI: 10.1007/s00347-025-02268-w

Petra Dávidová, Thomas Kohnen

{"title":"[From indications to outcome-A concise overview of supplementary intraocular lenses].","authors":"Petra Dávidová, Thomas Kohnen","doi":"10.1007/s00347-025-02268-w","DOIUrl":"10.1007/s00347-025-02268-w","url":null,"abstract":"Supplementary intraocular lenses (IOLs) are used to correct spherical and astigmatic refractive errors after cataract surgery. They provide patients with improved uncorrected visual acuity, resulting in a higher degree of spectacle independence. For the implantation of supplementary IOLs two approaches are distinguished: the primary and secondary Duet procedures. Indications include extreme refractive errors, desire for reversible multifocality, residual refractive errors and pediatric cataract surgery. Monofocal, extended depth of focus (EDOF) and multifocal implants are available, some also as toric variants. Thanks to specialized IOL designs, supplementary IOLs have been optimized for implantation in the ciliary sulcus, making the procedure safe, effective and associated with minimal complications. Several studies have demonstrated the favorable safety profile, predictable refractive outcomes and improvement in uncorrected visual acuity. Continuous advancements in IOL design, including the availability of EDOF and multifocal implants, have further enhanced the benefits of supplementary IOLs. Through a relatively small, low-risk and quick procedure, individualized solutions can be provided for many patients, improving vision and reducing spectacle dependence.","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"685-692"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144683725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Characterization of periocular basal cell carcinoma in patients ≤ 50 years from 1996-2024 : A retrospective analysis at a university eye clinic]. [1996-2024年间≤ 患者眼周基底细胞癌的特征：一所大学眼科诊所的回顾性分析]。

IF 0.6

Die Ophthalmologie Pub Date : 2025-09-01 Epub Date: 2025-08-06 DOI: 10.1007/s00347-025-02273-z

Jonathan Meinke, Karin U Löffler, Yannick N Liermann, Frank G Holz, Martina C Herwig-Carl

{"title":"[Characterization of periocular basal cell carcinoma in patients ≤ 50 years from 1996-2024 : A retrospective analysis at a university eye clinic].","authors":"Jonathan Meinke, Karin U Löffler, Yannick N Liermann, Frank G Holz, Martina C Herwig-Carl","doi":"10.1007/s00347-025-02273-z","DOIUrl":"10.1007/s00347-025-02273-z","url":null,"abstract":"Background: Basal cell carcinoma (BCC) is rare in patients ≤ 50 years and can be associated with tumor predisposition syndromes (TPDS). The BAP1-TPDS is particularly relevant for ophthalmologists as it is associated with other malignant nonocular tumors.Objective: Retrospective analysis of patients ≤ 50 years with periocular BCC with respect to demographic, clinical and histological features for the identification of TPDS including BAP1 staining as a possible screening procedure for BAP1-TPDS.Material and methods: Identification of all patients ≤ 50 years with histologically confirmed BCC surgically treated at this hospital in the period 1996-2024. Documentation of the localization and histological subtype as well as evaluation of the immunohistochemical BAP1 staining.Results: During the observational period 38 patients ≤ 50 years with a BCC of the ocular adnexa were identified including 5 patients with multiple BCC. The average age of the patients at the time of excision was 42.7 years. The histological growth pattern was predominantly nodular (89%) and the localization of the tumors was in decreasing order the lower eyelid (53%), medial eyelid angle (26%) and upper eyelid (21%). Of the patients two had a TPDS (Gorlin-Goltz syndrome and xeroderma pigmentosum). The majority of the tumors examined showed a clear BAP1 staining reaction (89%), A proportion of positive tumor cells below 25% was present in only 4 patients.Conclusion: In the case of patients ≤ 50 years with BCC or with other tumor entities, a TPDS should be considered. The BAP1 staining is interesting in this respect as it could represent an economically favorable screening method for a BAP1-TPDS and is possible without any substantial increase in labor costs.","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"708-715"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0